Hemilembolo, Marlhand C.
Campillo, Jérémy T.
Niama, Ange Clauvel
Pion, Sébastien D. S.
Missamou, François
Boussinesq, Michel
Bileckot, Richard R.
Chesnais, Cédric B.
Funding for this research was provided by:
Agence Nationale de la Recherche (18-CE17-0008)
Article History
Received: 9 May 2023
Accepted: 14 November 2023
First Online: 9 December 2023
Declarations
:
: This screening was carried out in a clinical trial evaluating the safety and efficacy of single doses of levamisole in individuals infected with <i>Loa loa</i>. This trial was approved by the Committee on Ethics in Health Sciences Research (no. 226/MRSIT/IRSSA/CERRSSA), and an Administrative Authorization (no. 469/MSP/CAB/UCPP-19) was released by the Ministry of Health and Population of the Congo.
: Not applicable.
: The authors declare that they have no competing interests.